SASPase-FLG2 Peptide Complex Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack effective tools for precisely determining the factors involved in epidermal homeostasis, particularly in the proliferation and differentiation of skin cells, and for screening active compounds that can modulate these processes in a rapid, sensitive, and cost-effective manner.

Innovation Solution

Isolated peptides derived from Filaggrin-2 and SASPase, which form a complex capable of modifying their three-dimensional conformation, are used to screen compounds that regulate skin cell proliferation and differentiation, employing specific amino acid sequences and nucleic acid sequences with at least 85% identity for affinity binding and modulating proteolytic activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional methods are used to study epidermal homeostasis, then general knowledge about skin function can be obtained, but precise determination of specific factors involved in cell proliferation and differentiation cannot be achieved

Engineering Contradiction:
Improveprecision of determining factors in epidermal homeostasisVSAvoidcomplexity of screening methods
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention segments the complex epidermal homeostasis system into specific molecular components by identifying and isolating the SASPase-FLG2 complex. This segmentation allows precise study of individual factors (SASPase and Filaggrin-2) and their interactions, enabling determination of specific factors involved in cell proliferation and differentiation without needing to analyze the entire complex system at once.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention introduces a fluorescent probe as an intermediary molecule that binds specifically to the SASPase-FLG2 complex. This intermediary enables detection and screening of compounds that modulate the complex's activity or conformation, providing a sensitive and specific tool for identifying factors involved in epidermal homeostasis with high precision.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If comprehensive screening of active compounds is performed to identify modulators of epidermal cell processes, then effective cosmetic or therapeutic agents can be found, but the screening process becomes time-consuming and expensive

Engineering Contradiction:
Improveeffectiveness of identified compounds in regulating skin cell homeostasisVSAvoidtime required for screening compounds
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The invention replaces complex, time-consuming biological assays with a fluorescent-based detection system. Instead of performing lengthy experiments to observe effects on cell proliferation and differentiation, the screening process uses fluorescent signal changes to rapidly identify compounds that modulate the SASPase-FLG2 complex, dramatically reducing screening time while maintaining reliability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention utilizes changes in fluorescent parameters (intensity, wavelength, polarization) as the SASPase-FLG2 complex interacts with modulating compounds. By monitoring these parameter changes, the system can rapidly identify active compounds based on their ability to alter the complex's conformation or activity, enabling fast and reliable screening without extensive time investment.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides a new, sensitive, and cost-effective method for identifying active compounds that can regulate skin cell homeostasis, addressing aesthetic and pathological disorders related to skin cell dysfunction.

Implementation Method 1

capable of affinity binding to an amino acid sequence derived from a SASPase

Methodology Applied
Scientific EffectAffinity binding:

Data Source

PatentEP2649090B1PEPTIDES THAT MODULATE COMPLEX SASPase-FLG2
Publication Date: 2018.08.22 LOREAL SA
  • EP2649090B1 patent drawingFigure 1
  • EP2649090B1 patent drawingFigure 2
  • EP2649090B1 patent drawing

AI summary

The invention relates to a peptide isolated from SASpase or FLG2, a fragment or homologue thereof, which can modify the three-dimensional shape of a complex formed by interaction between a first amino acide sequence from Filaggrin-2 and a second amino acid sequence from SASPase.